Pharmaceuticals · cGMP Consulting
cGMP Consulting for Pharmaceutical Manufacturers
The short answer
cGMP consulting for a drug manufacturer means making 21 CFR Parts 210 and 211 operable in your facility — with procedures your staff can follow, records that reconstruct what happened and a quality unit with the authority to act. We work at the level of the actual operation, not at the level of a policy manual.
01
Why this matters
- Most cGMP findings trace back to a small number of systems: production controls, laboratory controls, quality unit responsibilities and records.
- Development-stage companies frequently underestimate how much cGMP structure is required before the first clinical or registration batch.
- A quality unit without genuine authority produces documentation of decisions it did not actually make.
02
Applicable regulations and standards
- 21 CFR Part 210
- Scope and definitions for current good manufacturing practice.
- 21 CFR Part 211
- cGMP for finished pharmaceuticals: organization, buildings, equipment, controls, records.
- ICH Q10
- Pharmaceutical quality system expectations across the product lifecycle.
- ICH Q7
- GMP for active pharmaceutical ingredients where the operation includes API manufacture.
03
What our consultants actually do
- Perform a systems-based cGMP gap assessment covering quality, facilities and equipment, materials, production, packaging and labeling, and laboratory controls
- Stand up first-time cGMP systems for development-stage companies entering clinical or commercial manufacture
- Rebuild the procedure architecture so document count falls while control improves
- Define quality unit structure, authority, batch release process and management review
- Support production directly: batch record design, in-process control practice, line clearance and right-first-time programs
- Run structured remediation programs with milestones, governance and effectiveness verification
04
Across the product lifecycle
01 / DEVELOP
Documentation discipline and material control established for clinical supply.
02 / SCALE
Facility, utility and equipment controls sized for commercial operation.
03 / TRANSFER
Quality agreements and oversight defined before the first transferred batch.
04 / VALIDATE
Validation status accurately reflected in the quality system.
05 / MANUFACTURE
Batch review, investigations, change control and release operating as designed.
06 / MAINTAIN
Metrics, internal audit and product quality review sustaining the system.
05
Problems we are usually called about
- Procedures that promise more than the operation can consistently perform
- Batch records that document conformance rather than what actually occurred
- Quality unit release decisions made without the underlying laboratory data reviewed
- Change control used as a notification system rather than an assessment
- Training records complete while the practice on the floor differs from the procedure
06
Typical deliverables
- Systems-based cGMP gap assessment report with risk-ranked findings
- Quality manual and procedure architecture map
- Remediation plan with owners, milestones and effectiveness checks
- Batch record and documentation practice redesign
- Quality metrics and management review framework
07
Frequently asked
- When does a development-stage company need a full cGMP quality system?
- Phase-appropriate cGMP applies to investigational product, and expectations increase substantially as you approach registration batches and commercial supply. The practical answer is that material control, documentation practices and a functioning quality unit should be in place before the first GMP campaign.
- Can cGMP consulting reduce our procedure count?
- Usually, yes. A large fraction of deviations in mature systems come from procedures that duplicate or contradict each other. Consolidating them and removing commitments the operation does not need to make typically improves compliance rather than weakening it.
- Do you support sites using contract manufacturers?
- Yes. Sponsor oversight of CMOs — quality agreements, person-in-plant, batch record review and periodic audit — is one of the most common engagements we run.
08
References
More for pharmaceuticals
cGMP, validation and manufacturing quality support for drug products.
- Process ValidationProcess validation for a drug product is a three-stage lifecycle: design the process and its control strategy, qualify commercial-scale performance, and then verify that the process stays in control for as long as it is used.
- Cleaning ValidationCleaning validation demonstrates that a documented cleaning procedure consistently reduces residues to scientifically justified limits on shared equipment.
- Technology TransferTechnology transfer succeeds or fails on what the receiving site is given: process understanding, not just a batch record.
- Quality SystemsA pharmaceutical quality system is the set of connected processes — documents, changes, deviations, CAPA, training, release, review — that keep product decisions defensible.
- IND CMC SupportSponsors filing an IND usually need two things at once: CMC content for the application and a quality system capable of overseeing clinical manufacturing.
- NDA Manufacturing SupportThis is the site-side companion to an NDA filing: making sure the validated process, the control strategy and the records at the manufacturing site match what the application says, and that the people there can explain it during a pre-approval inspection..
Start a project
Tell us what you're working on.
Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.